Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $5.46 billion. The enterprise value is $4.97 billion.

Market Cap	5.46B
Enterprise Value	4.97B

Important Dates

The next estimated earnings date is Monday, August 10, 2026, before market open.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

ORKA has 60.31 million shares outstanding. The number of shares has increased by 85.49% in one year.

Current Share Class	60.31M
Shares Outstanding	60.31M
Shares Change (YoY)	+85.49%
Shares Change (QoQ)	+1.38%
Owned by Insiders (%)	2.27%
Owned by Institutions (%)	74.59%
Float	51.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	9.39
P/TBV Ratio	11.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.76, with a Debt / Equity ratio of 0.00.

Current Ratio	23.76
Quick Ratio	23.38
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -27.31% and return on invested capital (ROIC) is -19.52%.

Return on Equity (ROE)	-27.31%
Return on Assets (ROA)	-18.91%
Return on Invested Capital (ROIC)	-19.52%
Return on Capital Employed (ROCE)	-27.34%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.39M
Employee Count	68
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +679.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+679.02%
50-Day Moving Average	66.87
200-Day Moving Average	40.45
Relative Strength Index (RSI)	75.20
Average Volume (20 Days)	1,600,829

Short Selling Information

The latest short interest is 6.37 million, so 10.57% of the outstanding shares have been sold short.

Short Interest	6.37M
Short Previous Month	6.25M
Short % of Shares Out	10.57%
Short % of Float	12.48%
Short Ratio (days to cover)	5.62

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-133.40M
Pretax Income	-116.25M
Net Income	-94.19M
EBITDA	-133.29M
EBIT	-133.40M
Earnings Per Share (EPS)	-$1.92

Full Income Statement

Balance Sheet

The company has $388.83 million in cash and $1.81 million in debt, giving a net cash position of $494.15 million or $8.19 per share.

Cash & Cash Equivalents	388.83M
Total Debt	1.81M
Net Cash	494.15M
Net Cash Per Share	$8.19
Equity (Book Value)	486.72M
Book Value Per Share	9.64
Working Capital	378.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$90.92 million and capital expenditures -$269,000, giving a free cash flow of -$91.19 million.

Operating Cash Flow	-90.92M
Capital Expenditures	-269,000
Depreciation & Amortization	110,000
Net Borrowing	n/a
Free Cash Flow	-91.19M
FCF Per Share	-$1.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-85.49%
Shareholder Yield	-85.49%
Earnings Yield	-1.72%
FCF Yield	-1.67%

Analyst Forecast

The average price target for ORKA is $142.17, which is 56.92% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$142.17
Price Target Difference	56.92%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 1:12.

Last Split Date	Sep 3, 2024
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	1